RKDA ARCADIA BIOSCIENCES INC revenue, earnings and financials

For the quarter ended June 30, 2026, ARCADIA BIOSCIENCES INC reported revenue of $1.44M (down 0.8% from a year earlier), net income of −$6.27M and diluted EPS of −$2.09; over the last four quarters revenue was $4.75M and net income −$11.1M; for the fiscal year ended December 2025 revenue was $4.86M, down 3.7% on the year before.

RKDA annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $4.86M, gross profit n/a, operating income −$2.50M, net income −$2.34M (margin -48.1%), EPS −$1.71
• Fiscal year ended Dec 2024: revenue $5.05M, gross profit n/a, operating income −$3.65M, net income −$7.04M (margin -139.5%), EPS −$5.17
• Fiscal year ended Dec 2023: revenue $4.45M, gross profit n/a, operating income −$6.10M, net income −$14.0M (margin -314.0%), EPS −$11.29
• Fiscal year ended Dec 2022: revenue $7.42M, gross profit n/a, operating income −$14.0M, net income −$15.4M (margin -207.3%), EPS −$25.65
• Fiscal year ended Dec 2021: revenue $6.78M, gross profit n/a, operating income −$35.5M, net income −$14.7M (margin -216.2%), EPS −$27.56

RKDA quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $1.44M (down 0.8% year over year), net income −$6.27M, EPS −$2.09
• Quarter ended Mar 31, 2026: revenue $1.10M (down 8.3% year over year), net income −$4.39M, EPS −$2.11
• Quarter ended Dec 31, 2025 (from the annual report): revenue $901K (down 25.8% year over year), net income −$1.34M, EPS −$0.97
• Quarter ended Sep 30, 2025: revenue $1.30M (down 15.3% year over year), net income $856K, EPS $0.62
• Quarter ended Jun 30, 2025: revenue $1.46M (up 11.4% year over year), net income −$4.46M, EPS −$3.26
• Quarter ended Mar 31, 2025: revenue $1.20M (up 21.6% year over year), net income $2.60M, EPS $1.90
• Quarter ended Dec 31, 2024 (from the annual report): revenue $1.22M (up 93.8% year over year), net income −$4.06M, EPS −$2.99
• Quarter ended Sep 30, 2024: revenue $1.54M (up 18.4% year over year), net income −$1.61M, EPS −$1.18
• Quarter ended Jun 30, 2024: revenue $1.31M (up 0.7% year over year), net income $1.06M, EPS $0.78
• Quarter ended Mar 31, 2024: revenue $987K (down 19.9% year over year), net income −$2.42M, EPS −$1.78
• Quarter ended Dec 31, 2023 (from the annual report): revenue $627K (up 151.0% year over year), net income −$2.86M, EPS $0.85
• Quarter ended Sep 30, 2023: revenue $1.30M (down 17.3% year over year), net income −$2.57M, EPS −$1.89
• Quarter ended Jun 30, 2023: revenue $1.30M (down 66.4% year over year), net income $823K, EPS $0.61
• Quarter ended Mar 31, 2023: revenue $1.23M (down 61.7% year over year), net income −$9.38M, EPS −$10.86
• Quarter ended Dec 31, 2022 (from the annual report): revenue −$1.23M (down 156.7% year over year), net income −$4.24M, EPS −$6.08
• Quarter ended Sep 30, 2022: revenue $1.57M (down 33.9% year over year), net income −$2.87M, EPS −$4.67
• Quarter ended Jun 30, 2022: revenue $3.86M (up 174.6% year over year), net income −$3.78M, EPS −$6.81
• Quarter ended Mar 31, 2022: revenue $3.22M (up 288.9% year over year), net income −$4.49M, EPS −$8.09
• Quarter ended Dec 31, 2021 (from the annual report): revenue $2.17M, net income −$9.28M, EPS −$27.33
• Quarter ended Sep 30, 2021: revenue $2.38M, net income −$2.18M, EPS −$0.10

RKDA cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow −$4.70M, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow −$9.63M, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow −$15.3M, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow −$14.0M, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow −$25.9M, share buybacks n/a

RKDA balance sheet

• Jun 30, 2026: cash $4.18M, total assets $5.89M, total liabilities $5.26M, shareholders' equity n/a
• Mar 31, 2026: cash $954K, total assets $5.32M, total liabilities $2.44M, shareholders' equity n/a
• Dec 31, 2025: cash $259K, total assets $6.55M, total liabilities $2.41M, shareholders' equity n/a
• Sep 30, 2025: cash $1.12M, total assets $8.58M, total liabilities $3.14M, shareholders' equity n/a
• Jun 30, 2025: cash $1.38M, total assets $7.79M, total liabilities $3.26M, shareholders' equity n/a
• Mar 31, 2025: cash $3.16M, total assets $13.0M, total liabilities $4.09M, shareholders' equity n/a
• Dec 31, 2024: cash $4.24M, total assets $13.5M, total liabilities $7.29M, shareholders' equity $6.22M
• Sep 30, 2024: cash $3.94M, total assets $15.2M, total liabilities $5.09M, shareholders' equity $10.3M

What is RKDA's revenue?

ARCADIA BIOSCIENCES INC reported $4.75M of revenue over its last four quarters, through June 30, 2026.

Is RKDA profitable?

No. ARCADIA BIOSCIENCES INC lost $11.1M over the last four quarters.

What is RKDA's EPS?

Diluted earnings per share over the last four quarters were −$4.55; −$2.09 in the latest quarter.

RKDA ownership and insider trades · All stocks